FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2026
Back to search
Official data from USPTO
TEXIPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
06/04/2026
Trademark type
Word
Nice classes
5
Filing date
04/24/2025
Registration date
03/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2026
Last transaction
06/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
LOREDO GASPAR,ALONSO
Law office
O30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
Norm J. Rich Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatmentnamely suppressionof tumors; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncologyfor the treatment of cancers; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations and substances in the nature of immunomodulators; pharmaceutical preparations and substances in the nature of immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations in the nature of anti-inflammatory preparations; chemical reagents for medical purposes in the field of oncology
Publications
History of USPTO decisions and trademark events.
20 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/13/2026
PUBO
PUBLISHED FOR OPPOSITION
01/13/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/15/2025
RFNT
REFUSAL PROCESSED BY IB
11/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2025
RFRR
REFUSAL PROCESSED BY MPU
11/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/23/2025
CNRT
NON-FINAL ACTION WRITTEN
09/22/2025
DOCK
ASSIGNED TO EXAMINER
09/15/2025
MAFR
APPLICATION FILING RECEIPT MAILED
06/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/24/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/19/2025
Continuous trademark protection
Get notified about every new filing that threatens TEXIPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.